The use of dopaminergic and stimulant drugs for the treatment of deprission

Journal of Psychosocial Nursing and Mental Health Services

Volumn 50, Issue 2, 2012, Pages 11-14

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857066238     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20120112-03     Document Type: Article

References (18)

1. Cassano, P., Lattanzi, L., Fava, M., Navari, S., -Battistini, G., Abelli, M., & Cassano, G.B. (2005). Ropinirole in treatment-resistant depression: A 16-week pilot study. Canadian Journal of Psychiatry, 50, 357-360.
2. Cassano, P., Lattanzi, L., Soldani, F., Navari, S., -Battistini, G., Gemignani, A., & Cassano, G.B. (2004). Pramipexole in treatmentresistant depression: An extended follow-up. Depression and Anxiety, 20, 131-138. 10.1002/ da.20038
3. Corrigan, M.H., Denahan, A.Q., Wright, C.E., -Ragual, R.J., & Evans, D.L. (2000). Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression and Anxiety, 11, 58-65. doi:10.1002/ (SICI)1520-6394(2000)11:2<58::AIDDA2>3.0.CO;2-H
4. Fava, M., Thase, M.E., DeBattista, C., Dogh-ramji, K., Arora, S., & Hughes, R.J. (2007). Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Annals of Clinical Psychiatry, 19, 153-159.
5. Fawcett, J., Kravitz, H.M., Zajecka, J.M., & -Schaff, M.R. (1991). CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. Journal of Clinical Psychopharmacology, 11, 127-132.
6. Frye, M.A., Grunze, H., Suppes, T., McElroy, S.L., Keck, P.E., Walden, J, Post, R.M. (2007). A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. American Journal of Psychiatry, 164, 1242-1249. doi:10.1176/appi. ajp.2007.06060981
7. Hardy, S.E. (2009). Methylphenidate for the -treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. American Journal of Geriatric Pharmacotherapy, 7, 34-59.
8. Inoue, T., Tsuchiya, K., Miura, J., Sakakibara, -S., Denda, K., Kasahara, T., & Koyama, T. (1996). Bromocriptine treatment of tricyclic -and heterocyclic antidepressant-resistant de-pression. Biological Psychiatry, 40, 151-153
9. Lundt, L. (2004). Modafinil treatment in patients with seasonal affective disorder/winter depression: An open-label pilot study. Journal of Affective Disorders, 81, 173-178.
10. Michelson, D., Adler, L.A., Amsterdam, J.D., -Dunner, D.L., Nierenberg, A.A., Reimherr, F.W, Williams, D.W. (2007). Addition of atomoxetine for depression incompletely responsive to sertraline: A randomized, oubleblind, placebo-controlled study. Journal of Clinical Psychiatry, 68, 582-587.
11. Naranjo, C.A., Tremblay, L.K., & Busto, U.E. (2001). The role of the brain reward system in depression. Progress in Neuro-Psychophar-macology and Biological Psychiatry, 25, 781-823. doi:10.1016/S0278-5846(01)00156-7
12. Pae, C.U., Marks, D.M., Masand, P.S., Peindl, K., Hooper-Wood, C., Han, C, Patkar, A.A. (2009). Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: Results from a 4-week double-blind placebo-controlled trial. Clinical Neuropharmacology, 32, 85-88.
13. Papakostas, G.I., Peterson, T.J., Burns, A.M., & -Fava, M. (2006). Adjunctive atomoxetine for residual fatigue in major depressive disorder. Journal of Psychiatric Research, 40, 370-373. doi:10.1016/j.jpsychires.2005.04.013
14. Patkar, A.A., Masand, P.S., Pae, C.U., Peindl, -K., Hooper-Wood, C., Mannelli, P., & Ciccone, P. (2006). A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatmentresistant depression. Journal of Clinical Psychopharmacology, 26, 653-656.
15. Ravindran, A.V., Kennedy, S.H., O'Donovan, -C., Fallu, A., Camacho, F., & Binder, C.E. (2008). Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: Results of a double-blind, randomized, placebocontrolled trial. Journal of Clinical Psychiatry, 69, 87-94.
16. Rogóz, Z., Skuza, G., Daniel, W.A., Wójcikowski, -J., Dudek, D., & Wróbel, A. (2007). Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression. Pharmacological Reports, 59, 778-784
17. Satel, S.L., & Nelson, J.C. (1989). Stimulants in -the treatment of depression: A critical overview. Journal of Clinical Psychiatry, 50, 241-249
18. Stryjer, R., Strous, R.D., Shaked, G., Bar, F., Feldman, B., Kotler, M, Weizman, A. (2003). Amantadine as augmentation therapy in the management of treatment-resistant depression. International Clinical Psychopharmacology, 8, 93-96.